IP Library › Patent Application 18160032
Patent Application
App. No. 18/160,032

Retroviral And Lentiviral Vectors

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/160,032
Abstract

The present invention provides a retroviral or lentiviral vector having a viral envelope which comprises a mitogenic T-cell activating transmembrane protein which comprises: (i) a mitogenic domain which binds a mitogenic tetraspanin, and (ii) a transmembrane domain; wherein the mitogenic T-cell activating transmembrane protein is not part of a viral envelope glycoprotein. When cells such as T-cells or Natural Killer cells are transduced by such a viral vector, they are activated by the mitogenic T-cell activating transmembrane protein.

Claims (31)

1 - 26 . (canceled)

27 . A kit for making a retroviral or lentiviral vector having a viral envelope comprising a mitogenic T-cell activating transmembrane protein, which kit comprises:

(i) a host cell which expresses, at the cell surface, the mitogenic T-cell activating transmembrane protein,

(ii) nucleic acids comprising gag, pol, env and optionally rev, and

(iii) a retroviral or lentiviral genome,

wherein the mitogenic T-cell activating transmembrane protein comprises:

(a) a mitogenic domain which binds a mitogenic tetraspanin and

(b) a transmembrane domain, and

wherein the mitogenic T-cell activating transmembrane protein is not part of a viral envelope glycoprotein.

28 . A kit for making a retroviral or lentiviral vector having a viral envelope comprising a mitogenic T-cell activating transmembrane protein, which kit comprises:

(i) a packaging cell which is a host cell that comprises one or more of the genes gag, pol, env and/or rev and that expresses, at the cell surface, a mitogenic T-cell activating transmembrane protein, and

(ii) a retroviral or lentiviral vector genome,

wherein the mitogenic T-cell activating transmembrane protein comprises:

(a) a mitogenic domain which binds a mitogenic tetraspanin and

(b) a transmembrane domain, and

wherein the mitogenic T-cell activating transmembrane protein is not part of a viral envelope glycoprotein.

29 . A kit for making a packaging cell, which kit comprises:

(i) one or more nucleic acid(s) encoding a mitogenic T-cell activating transmembrane protein, and

(ii) nucleic acids comprising retroviral gag, pol, env and optionally rev genes,

wherein the mitogenic T-cell activating transmembrane protein comprises:

(a) a mitogenic domain which binds a mitogenic tetraspanin and

(b) a transmembrane domain, and

wherein the mitogenic T-cell activating transmembrane protein is not part of a viral envelope glycoprotein.

30 . A kit for making a producer cell, which kit comprises:

(i) one or more nucleic acid(s) encoding a mitogenic T-cell activating transmembrane protein,

(ii) nucleic acids comprising retroviral gag, pol, and env and optionally rev genes,

(iii) a retroviral or lentiviral vector genome,

wherein the mitogenic T-cell activating transmembrane protein comprises:

(a) a mitogenic domain which binds a mitogenic tetraspanin and

(b) a transmembrane domain, and

wherein the mitogenic T-cell activating transmembrane protein is not part of a viral envelope glycoprotein.

Assignments (2)
PATENT SECURITY AGREEMENT Recorded Jul 30, 2026
From: AUTOLUS LIMITED
To: PERCEPTIVE CREDIT HOLDINGS V, LP, AS ADMINISTRATIVE AGENT
Reel/Frame 076084/0283 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 5, 2023
From: PEDDAREDDIGARI, VIJAY; BESWICK, RICHARD; SHORT, JOHN; PULÉ, MARTIN; KOTSOPOULOU, EKATERINI
To: AUTOLUS LIMITED
Reel/Frame 063551/0421 →